Cargando…
Abnormal platelet aggregation in pediatric pulmonary hypertension
Endogenous prostacyclin stimulates pulmonary vasodilation and inhibits platelet aggregation. For the synthetic analog treprostinil, used in the treatment of pulmonary hypertension (PH), conflicting, anecdotal evidence exists regarding its effects on clinically relevant platelet function. This study...
Autores principales: | Handler, Stephanie S., Jin, Jing, Ogawa, Michelle T., Feinstein, Jeffrey A., Lo, Clara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294293/ https://www.ncbi.nlm.nih.gov/pubmed/35864911 http://dx.doi.org/10.1002/pul2.12104 |
Ejemplares similares
-
Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients
por: Siehr, Stephanie L., et al.
Publicado: (2015) -
Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension
por: Blalock, Shannon, et al.
Publicado: (2013) -
Right ventricular stroke work correlates with outcomes in pediatric pulmonary arterial hypertension
por: Yang, Weiguang, et al.
Publicado: (2018) -
Central line replacement following infection does not improve reinfection rates in pediatric pulmonary hypertension patients receiving intravenous prostanoid therapy
por: McCarthy, Elisa K., et al.
Publicado: (2018) -
Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension network
por: Handler, Stephanie S., et al.
Publicado: (2022)